European Pharmaceutical Review

MAY 22, 2023

The review stated that therapeutic innovation has resulted in the production of expensive drugs to treat rare diseases, which need to be available on time. Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags.

90

90

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. However, more highly innovative/high-cost treatments, within infectious disease and neurology space, are likely to enter the market for rare disorders, increasing the number of non-oncology RSAs.

FDA 105

FDA 105

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. A refund up to 12 inpatient doses will also be offered for patients whose disease worsens while receiving treatment.

Documentation 52

Documentation Immunization Pharmaceutical Companies Pharmaceutical Companies 52